Ian Frederick Smith occupies the position of Chairman of Solid Biosciences, Inc. and Executive Chairperson at ViaCyte, Inc.

He is also on the board of Vertex Pharmaceuticals (Canada), Inc. and Vertex Pharmaceuticals (U.K.) Ltd. and Member of The Financial Executives Institute, Member of The American Institute of Certified Public Accountants and Member of Institute of Chartered Accountants in England & Wales.

Mr. Smith previously was EVP, Chief Operating & Financial Officer at Vertex Pharmaceuticals, Inc. and Co-Managing Director at Vertex Pharmaceuticals (Germany) GmbH (a subsidiary of Vertex Pharmaceuticals, Inc.) and Partner-Life Science & Technology Practice Group at Ernst & Young LLP.

He received an undergraduate degree from Manchester Metropolitan University of.